VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

The Indonesian government is interested in participating in a tuberculosis vaccine (TBC) clinical trial to the Bill & Melinda Gates Foundation (BMGF) and the Welcome Trust. The two philanthropic foundations have received the letter of application and support the handling of TB in Indonesia.

President of Global Health of BMGF, Trevor Mundel said that his party supports the handling of TB in Indonesia and has received a letter from the Indonesian government regarding Indonesia's plan to participate in clinical trials of TB vaccine development.

As an illustration, BMGF is conducting clinical trials of TB vaccines in Africa and the interest in participation that Indonesia is aiming for will be its own consideration for its coverage. This clinical trial also involves the functions of the European Medicine Agency (EMA) and WHO. The TB vaccine is planned to be produced in 2027.

“If it will be carried out in Indonesia, it will take a total of 26,000 samples. Later, it will require the support of the Indonesian government, especially coordination with BPOM, "Mundel said in his statement, quoted from the official website of the Indonesian Ministry of Health, Saturday (24/9/2022).

The Indonesian Minister of Health, Budi Gunadi Sadikin, said that he would facilitate coordination with a number of parties, including BPOM, for the implementation of clinical trials in Indonesia.

According to the Minister of Health, this effort is in line with the health transformation that is being built in Indonesia, especially pillar one and pillar six, namely the transformation of primary services based on information technology and the latest health technology.

"The various health system transformation agendas are being carried out in Indonesia with concrete targets that have been announced," said Minister of Health Budi. (RRI)